Pressurized IntraThoracic Aerosol Chemotherapy (PITAC) directed therapy of patients with malignant pleural effusion and pleural metastasis

Hansen Pernille Schjødt; Graversen Martin; Detlefsen Sönke; Ainsworth Alan Patrick; Mortensen Michael Bau

doi:10.1515/pp-2024-0008

Pleura and Peritoneum (Nov 2024)

Pressurized IntraThoracic Aerosol Chemotherapy (PITAC) directed therapy of patients with malignant pleural effusion and pleural metastasis

Hansen Pernille Schjødt,
Graversen Martin,
Detlefsen Sönke,
Ainsworth Alan Patrick,
Mortensen Michael Bau

Affiliations

Hansen Pernille Schjødt: Odense PIPAC Center (OPC) and Odense Pancreas Center (OPAC), Odense University Hospital, Odense, Denmark
Graversen Martin: Odense PIPAC Center (OPC) and Odense Pancreas Center (OPAC), Odense University Hospital, Odense, Denmark
Detlefsen Sönke: Odense PIPAC Center (OPC) and Odense Pancreas Center (OPAC), Odense University Hospital, Odense, Denmark
Ainsworth Alan Patrick: Odense PIPAC Center (OPC) and Odense Pancreas Center (OPAC), Odense University Hospital, Odense, Denmark
Mortensen Michael Bau: Odense PIPAC Center (OPC) and Odense Pancreas Center (OPAC), Odense University Hospital, Odense, Denmark

DOI: https://doi.org/10.1515/pp-2024-0008
Journal volume & issue: Vol. 9, no. 4
pp. 131 – 139

Abstract

Read online

Pressurized IntraThoracic Aerosol Chemotherapy (PITAC) has been suggested as a new therapy for patients with malignant pleural effusion (MPE) and/or pleural metastasis (PLM). The patients have a poor prognosis with a median survival of 3 to 12 months. We present feasibility, patient safety, and cytological/histological response assessment in PITAC-treated patients with MPE and/or PLM.

Published in Pleura and Peritoneum

ISSN: 2364-768X (Online)
Publisher: De Gruyter
Country of publisher: Germany
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine
Website: https://www.degruyter.com/view/journals/pp/pp-overview.xml

About the journal

Abstract

Keywords